Diagnosis and management of histoplasmosis

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
L J Wheat

Abstract

Histoplasmosis occurs throughout the world but is more common within the endemic areas of North America, particularly in fertile river valleys. Disease manifestations range from asymptomatic infection in the normal host with low-inoculum exposure to rapidly fatal, disseminated infection in the severely immunocompromised host, emphasizing the importance of cellular immunity in defense against Histoplasma capsulatum. Diagnosis depends on a high index of suspicion, knowledge of the clinical and epidemiologic features of the infection, and a thorough understanding of the uses and limitations of fungal cultural and serological laboratory procedures. Recently, a method has been developed for rapid diagnosis based on detection of a polysaccharide antigen in body fluids of patients with histoplasmosis. Amphotericin B remains the preferred treatment for more severe forms of histoplasmosis, particularly in the immunocompromised host, but oral treatment with ketoconazole or newer imidozoles appears to be effective in less severe infections in non-immunocompromised individuals.

References

Apr 1, 1979·American Journal of Epidemiology·A F DiSalvo, W M Johnson
Jan 1, 1978·The American Journal of Medicine·S F DaviesG A Sarosi
Nov 1, 1976·Medicine·R A GoodwinR M Des Prez
Mar 1, 1986·Journal of Clinical Microbiology·J WheatR P Tewari
Feb 1, 1989·Archives of Internal Medicine·L J WheatM L French
Sep 1, 1988·Medicine·J E LoydR M Des Prez
Aug 1, 1987·The Journal of Infectious Diseases·C V PayaF R Cockerill
Aug 1, 1987·The Journal of Infectious Diseases·C V PayaH A Homburger
Aug 1, 1986·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·J J SacksL K Crockett
Mar 1, 1987·Infection and Immunity·K R Klimpel, W E Goldman
Feb 1, 1985·The American Journal of Medicine·L J WheatM L Zeckel
Apr 1, 1972·Annals of Internal Medicine·J W Smith, J P Utz
Mar 1, 1973·The American Journal of Medicine·A L BrodskyG F Mallison
Jan 1, 1970·Mycopathologia et mycologia applicata·G SotgiuA Mazzoni
Jan 1, 1970·Mycopathologia et mycologia applicata·H S Randhawa
Jul 30, 1970·The New England Journal of Medicine·J D ParkerF E Tosh
May 1, 1970·The American Journal of Medicine·P ReddyH Larsh
Oct 1, 1984·The Journal of Pediatrics·W T Hughes
Nov 1, 1983·The American Journal of Medicine·P F LehmannE H Freimer
Jan 24, 1983·The American Journal of Medicine·T G Slama
Apr 1, 1983·Archives of Internal Medicine·L J WheatM V French
Mar 1, 1984·Journal of Clinical Immunology·D G PayanR H Rubin
Sep 1, 1983·American Journal of Epidemiology·W F SchlechJ D Band
Sep 1, 1983·Arthritis and Rheumatism·J RosenthalT G Slama
Jan 1, 1983·American Journal of Epidemiology·R J WaldmanD W Fraser
Jan 1, 1980·The American Journal of Tropical Medicine and Hygiene·S H Siddiqi, J C Stauffer
Jul 1, 1981·Medicine·R A GoodwinR M Des Prez

❮ Previous
Next ❯

Citations

Nov 30, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J GascónM Corachan
Jun 1, 2001·Current Infectious Disease Reports·Carol A. Kauffman
Jul 1, 1995·International Journal of Antimicrobial Agents·J E Mangino, P G Pappas
Oct 19, 2000·The New England Journal of Medicine·A P LimayeW E Stamm
Oct 1, 1996·The Pediatric Infectious Disease Journal·T S BorjaR J Leggiadro
Aug 23, 2006·Cardiology in Review·Jessica J Wang, Sharon C Reimold
Feb 1, 1992·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·G S HeinicJ S Greenspan
Sep 28, 2001·Journal of Clinical Microbiology·M D LindsleyC J Morrison
Sep 1, 1993·The British Journal of Radiology·R M WilliamsJ Brennan
Nov 3, 2007·Mayo Clinic Proceedings·Jason C SchultzRandall S Edson
Nov 17, 1998·Journal of Travel Medicine·P NastaS Casari
Feb 1, 1994·Oral Surgery, Oral Medicine, and Oral Pathology·S SwindellsL Kaufman
Feb 23, 2011·Revista Da Sociedade Brasileira De Medicina Tropical·Vicente Sperb AntonelloLuiz Carlos Severo
Sep 17, 2013·Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·Ines E LautenschlaegerMartin Kramer
Jul 1, 1997·Pediatric Pulmonology·J P ShafferE Allen
Dec 13, 2019·Case Reports in Infectious Diseases·Chiara PapaliniMaria Bruna Pasticci
Apr 12, 2000·Journal of Travel Medicine·J GascónM Corachán
May 3, 1991·Klinische Wochenschrift·J K RockstrohS Ewig
Aug 21, 2018·Journal of the Pediatric Infectious Diseases Society·Christopher P OuelletteMonica I Ardura
May 19, 2009·Revista Da Sociedade Brasileira De Medicina Tropical·Marcelo Simão Ferreira, Aércio Sebastião Borges
Apr 2, 2021·Frontiers in Cellular and Infection Microbiology·Mathieu NacherPierre Couppié
Jan 5, 1999·Clinical and Diagnostic Laboratory Immunology·C V PizziniJ M Peralta
Oct 8, 1997·Journal of Clinical Microbiology·B L GomezR J Hay
Mar 20, 1999·Infection and Immunity·R M Zancopé-OliveiraG S Deepe
Apr 2, 2016·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Sayaka Asahata-TagoKen Kikuchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.